| Literature DB >> 28743554 |
Elodie Macho-Fernandez1, Neila Chekkat2, Christophe Ehret2, Jean-Sébastien Thomann2, Marcella De Giorgi2, Maria Vittoria Spanedda2, Line Bourel-Bonnet2, Didier Betbeder3, Béatrice Heurtault4, Christelle Faveeuw1, Sylvie Fournel5, Benoît Frisch2, François Trottein1.
Abstract
The potent antitumor effect of α-galactosylceramide (α-GalCer) is based on its recognition by invariant Natural Killer T cells (iNKT) after its capture and presentation by antigen presenting cells including dendritic cells (DCs). Synthetic α-GalCer has already been tested in advanced cancer patients but no or only moderate clinical responses were obtained. To optimize α-GalCer efficacy, we have postulated that alternative formulations impacting its molecular organization in aqueous medium could modify DC uptake and iNKT-based immune responses. To this end, we have developed two strategies: (1) the formulation of α-GalCer in non-cationic liposomes and (2) the synthesis of a water-soluble α-GalCer analogue by anchoring a polyethyleneglycol moiety on its sugar head. The biological activities of these new preparations were compared to that induced by the classically used Polysorbate 20 α-GalCer micelles. Both formulations retained their uptake by DCs and activated iNKT cells both in vitro and in vivo. Despite a lower cytokine production, the formulations induced a potent immune response able to control lung murine carcinoma. In conclusion, it is possible to increase α-GalCer solubility in aqueous solution without limiting its antitumor properties.Entities:
Keywords: Cancer; Liposomes; Micelles; Water-soluble α-GalCer; iNKT; α-GalCer formulations
Mesh:
Substances:
Year: 2017 PMID: 28743554 DOI: 10.1016/j.ijpharm.2017.07.054
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875